Copper Histidinate Treatment for Menkes Disease
Clinical trial NCT04074512 · APPROVED_FOR_MARKETING
Trial details
- NCT number
- NCT04074512
- Sponsor
- Sentynl Therapeutics, Inc.
- Status
- APPROVED_FOR_MARKETING
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.